Akebia Therapeutics, Inc. (AKBA)

NASDAQ

$0.59

$-0.03

(-5.14%)

Regular Market

Akebia Therapeutics, Inc. (AKBA) Live Price Chart

Last updated: ⁦2026-10-21 18:49:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Akebia Therapeutics, Inc. (AKBA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.59, with a market capitalization of $188.46M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.57 to $3.20. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$188.46M
Open	$0.61
Day's High	$31.00
Day's Low	$0.24
Previous Close	$0.62
Volume	13.93M
Average Volume	6.98M
P/E Ratio	--
52-Week High	$3.20
52-Week Low	$0.57
Dividend Yield	--
Earnings Date	--

Akebia Therapeutics, Inc. (AKBA) Stock Price Today

Akebia Therapeutics, Inc. (AKBA) is currently trading at $0.59 as of 2026-10-21 18:32:49, down 5.19% ($0.03) from the previous close of $0.62

During today's regular trading session, AKBA has traded between $0.24 and $31.00, with a trading volume of 13.93M shares. The current price is near the lower end of today's range.

Akebia Therapeutics, Inc. (AKBA) 7-Day Stock Price Change

Over the past seven days, Akebia Therapeutics, Inc. (AKBA) moved from $0.79 to $0.59, representing a decline of 25.84% ($0.20).

The stock traded between $0.57 and $0.81 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 9.02 million shares, up versus the previous seven-day period, indicating higher trading activity.

AKBA 52-Week Price Position

Position in Range: 0.5%

52W Low$0.57

52W High$3.20

AKBA is currently trading at $0.59, placing it 0.5% of the way from its 52-week low of $0.57 to its 52-week high of $3.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Akebia Therapeutics, Inc. (AKBA)?

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Akebia Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	194
Exchange	NASDAQ
Company Website	https://www.akebia.com

How to Buy Akebia Therapeutics, Inc. (AKBA) Stock on MEXC

Eligible investors can buy real shares of Akebia Therapeutics, Inc. (AKBA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AKBA and Place Your Order

Open the RealStocks trading page and search for AKBA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Akebia Therapeutics, Inc. (AKBA) stock price today?

Akebia Therapeutics, Inc. (AKBA) is currently trading at $ 0.59, down 5.19% ($0.03) from the previous close of $ 0.62. Intraday prices update in real time during regular trading hours.

2.Is AKBA stock going up or down today?

As of 2026-10-21 18:32:49, AKBA is trading at $ 0.59, down 5.19% ($0.03) from its previous close of $ 0.62. The stock has traded between $ 0.24 and $ 31.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is AKBA pre-market price?

As of 2026-10-21 18:32:49, AKBA is trading at $ 0.63 in pre-market trading, up 1.12% ($0.01) from the previous close of $ 0.62. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AKBA after-hours price?

As of 2026-10-21 18:32:49, AKBA is trading at $ 0.62 in after-hours trading, up 0.95% ($0.01) from the regular-session close of $ 0.62. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AKBA stock trading now?

AKBA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AKBA sit relative to its 52-week high and low?

Over the past 52 weeks, AKBA has traded between a low of $ 0.57 and a high of $ 3.20. At $ 0.59, the stock is positioned 0.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Akebia Therapeutics, Inc. in?

Akebia Therapeutics, Inc. (AKBA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Akebia Therapeutics, Inc.'s market capitalization and where is it listed?

Akebia Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 188.46M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AKBA valued in terms of P/E ratio and EPS?

AKBA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.11. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Akebia Therapeutics, Inc. pay a dividend?

Akebia Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.